Non-contrast chest CT-derived epicardial adipose tissue volume index and major adverse cardiovascular events after PCI for acute myocardial infarction: a retrospective cohort study
This retrospective cohort study demonstrates that epicardial adipose tissue volume index (EATVI) derived from routine non-contrast chest CT is an independent predictor of major adverse cardiovascular events after percutaneous coronary intervention for acute myocardial infarction and significantly improves prognostic accuracy beyond the conventional GRACE score.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a heart attack strikes, it is often because a blood vessel feeding the heart muscle has suddenly become blocked. Doctors can usually clear this blockage with a procedure called percutaneous coronary intervention, which involves threading a tiny balloon and a mesh tube, known as a stent, through the arteries to push the plaque aside and restore blood flow. For many patients, this treatment is a success; the vessel is open, and the immediate danger passes. Yet, the story does not always end there. Even after a successful procedure, the heart remains vulnerable. Some patients go on to suffer further heart attacks, develop heart failure, or face other serious complications. The medical community has long sought better ways to predict who is at risk for these future events, looking beyond the standard clinical checklists to find hidden biological clues that might signal trouble ahead.
One such clue lies in a layer of fat that sits directly on the surface of the heart. Unlike the fat stored under the skin or around the belly, this specific tissue, called epicardial adipose tissue, wraps around the heart muscle and the coronary arteries like a soft cushion. Because it sits so close to the heart, it is not just a passive storage depot; it acts more like an active organ, releasing chemicals that can inflame the nearby blood vessels and the heart muscle itself. Scientists have suspected that a larger amount of this fat might be a warning sign of future heart trouble, but measuring it precisely has been difficult. Furthermore, simply knowing the total amount of fat is not enough, because a larger person naturally has more fat than a smaller person. To get a fair comparison, researchers needed a way to measure this fat relative to the size of the patient's body, creating a standardized index that could reveal the true burden of this tissue regardless of the patient's build.
A team of researchers at the First Affiliated Hospital of Anhui Medical University set out to test whether this standardized measurement could help predict future heart events in patients who had just undergone successful heart attack treatment. They focused on a group of 367 patients who had received stents for an acute myocardial infarction. After the procedure, while the patients were still in the hospital, the team reviewed routine chest scans that had been taken without the use of contrast dye. These scans, which are commonly done to check the lungs or other chest structures, also contain clear images of the heart and the fat surrounding it. Using specialized software, the researchers carefully traced the boundaries of this fat layer on the scans, calculated its total volume, and then divided that number by the patient's body surface area. This calculation produced what they call the epicardial adipose tissue volume index, a number that represents how much of this specific fat a person carries relative to their body size.
The researchers then followed these patients for a median period of just over two years to see who would experience a major adverse cardiovascular event. These events included death from heart causes, a new heart attack, or hospitalization for worsening heart failure or unstable angina. The results showed a clear pattern: patients with higher levels of this indexed fat were significantly more likely to suffer these complications. When the group was divided into three equal parts based on their fat index, the lowest group had a complication rate of about 16 percent, while the highest group saw that rate rise to over 31 percent. This trend held true even after the researchers accounted for other known risk factors such as age, diabetes, high blood pressure, kidney function, and the severity of the blockages found in the heart arteries. In fact, for every specific increase in this fat index, the risk of a future event rose by nearly 50 percent, suggesting that the fat itself carries information about risk that standard clinical scores do not capture.
To make these findings useful for doctors, the team developed a simplified prediction tool. They combined the fat index with four other factors that are easy to find in a patient's medical record: whether the patient has diabetes, the severity of their coronary artery blockages, and their heart function and stability at the time of the heart attack. When they tested this new tool against the widely used GRACE score, which is the current standard for assessing risk in heart attack patients, the new model performed better. It was more accurate at distinguishing between patients who would remain healthy and those who would face future events. The researchers also created a simple point system based on this model, allowing a doctor to quickly sort patients into low, intermediate, or high-risk groups. Those in the high-risk group, defined by the score, faced a future complication rate of nearly 48 percent, compared to just 11 percent for the low-risk group.
The study suggests that this fat layer, when measured correctly from a routine scan, offers a window into the lingering metabolic and inflammatory risks that remain after a heart attack. It appears to act as a biological marker that reflects the body's overall struggle with heart disease, independent of the immediate blockage that was fixed. However, the authors are careful to note that this work is a first step. The study was conducted at a single hospital, and the prediction tool needs to be tested in other populations to confirm its reliability. Before this method becomes a standard part of heart care, larger studies will be needed to prove that the results hold true across different hospitals and patient groups. For now, the research provides a compelling reason to look closer at the fat surrounding the heart, offering a potential new way to identify patients who might need more intensive care and closer monitoring to prevent their next heart event.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.